CVS HEALTH Corp
For the period ended Jun 30, 2024. Filed Aug 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(c) Stock Repurchases
The following table presents the total number of shares purchased in the three months ended June 30, 2024, the average price paid per share and the approximate dollar value of shares that still could have been purchased at the end of the applicable fiscal period, pursuant to the share repurchase programs authorized by CVS Health Corporation’s Board of Directors on November 17, 2022 and December 9, 2021. See Note 8 ‘‘Shareholders’ Equity’’ contained in “Notes to Condensed Consolidated Financial Statements (Unaudited)” in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information.
| Fiscal Period · Total Numberof SharesPurchased · AveragePrice Paid perShare · Total Number of SharesPurchased as Part ofPublicly AnnouncedPlans or Programs · Approximate DollarValue of Shares thatMay Yet BePurchased Under thePlans or Programs | |||||
|---|---|---|---|---|---|
| April 1, 2024 through April 30, 2024 | — | $— | — | $11,500,000,143 | |
| May 1, 2024 through May 31, 2024 | — | $— | — | $11,500,000,143 | |
| June 1, 2024 through June 30, 2024 | — | $— | — | $11,500,000,143 | |
| — | — | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.